Added therapeutic value of new drugs approved in Brazil from 2004 to 2016.

Hoefler R, Alves TL, Leufkens HG, Naves JOS

Open source

DOI: 10.1590/0102-311x00070018
Published: 2019 May 23
Container: Cadernos de saude publica
Publisher: Not recorded
Open access: no

Credibility signals

uncertain Score 51/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1590/0102-311x00070018,
  title = {Added therapeutic value of new drugs approved in Brazil from 2004 to 2016.},
  author = {Hoefler R and Alves TL and Leufkens HG and Naves JOS},
  year = {2019},
  journal = {Cadernos de saude publica},
  doi = {10.1590/0102-311x00070018},
  url = {https://doi.org/10.1590/0102-311x00070018}
}

RIS

TY  - JOUR
TI  - Added therapeutic value of new drugs approved in Brazil from 2004 to 2016.
AU  - Hoefler R
AU  - Alves TL
AU  - Leufkens HG
AU  - Naves JOS
PY  - 2019
JO  - Cadernos de saude publica
DO  - 10.1590/0102-311x00070018
UR  - https://doi.org/10.1590/0102-311x00070018
ER  -

APA

R, H., TL, A., HG, L., & JOS, N. (2019). Added therapeutic value of new drugs approved in Brazil from 2004 to 2016.. Cadernos de saude publica. https://doi.org/10.1590/0102-311x00070018

Source records

pubmed · retrieved 2026-09-26T12:32:58.754Z
europe-pmc · retrieved 2026-09-26T12:32:58.748Z
doaj · retrieved 2026-09-26T12:32:58.729Z